Dawn Hill's Colleagues at QED Therapeutics
Dawn Hill's Contact Details
HQ
650-231-4088
650-231-4088
Location
Company
QED Therapeutics
QED Therapeutics
Dawn Hill's Company Details
QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.
Frequently Asked Questions about Dawn Hill
Dawn Hill currently works for QED Therapeutics.
Dawn Hill's role at QED Therapeutics is VP, Clinical Operations.
Dawn Hill's email address is ***@qedtx.com. To view Dawn Hill's full email address, please signup to ConnectPlex.
Dawn Hill works in the Biotechnology industry.
Dawn Hill's colleagues at QED Therapeutics are Mike Monteith, Stacie Shepherd, Todd Bobick, Mar Reyes, Lihua Zhang, Brian Eater, Yen Nguyen and others.
Dawn Hill's phone number is 650-231-4088